Abstract
Rationale
After reports of adverse effects with hormone replacement therapy, such as reproductive and breast cancer and coronary heart disease, much attention has been given to the development of new remedies to alleviate menopausal depression in women, but methods for their preclinical evaluation have not been clarified. We previously developed a procedure to predict the drug effect on the menopausal depressive-like state in female mice.
Objectives
We attempted to identify psychoactive components from ginseng root, one of the earliest known materials for menopausal disorder, and to clarify the possible mechanism involved.
Methods
As an index of a depressive-like state, we used the prolongation of immobility time induced by an ovariectomy during the forced swimming test. Chronic treatment with the candidate substance began the day after ovariectomy and continued for 14 days. To examine whether the 5-HT2A receptor antagonist ritanserin antagonized the antidepressant-like effect of ginsenoside Rb1, ritanserin was given as pretreatment 15 min before the daily administration of ginsenoside Rb1 and the antagonistic effect was compared with ginsenoside Rb1 alone.
Results
Ginsenoside Rb1 and compound K were active ingredients that dose-dependently prevented the prolongation of immobility time induced by ovariectomy. Co-administration of ritanserin, a 5-HT2A-receptor antagonist, antagonized the effect of ginsenoside Rb1.
Conclusions
We suggest that ginsenoside Rb1 and its metabolite, compound K, are antidepressant-like components of the ginseng root, and that 5-HT2A receptors may play an important role in mediating the antidepressant-like effect of ginsenoside Rb1.
Similar content being viewed by others
References
Akao T, Kanaoka M, Kobashi K (1998) Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administration: measurement of compound K by enzyme immunoassay. Biol Pharm Bull 21:245–249
Andersen K, Liljefors T, Gundertofte K, Perregaard J, Bogeso KP (1994) Development of a receptor-interaction model for serotonin 5-HT2 receptor antagonists. Predicting selectivity with respect to dopamine D2 receptors. J Med Chem 37:950–962
Bekku N, Yoshimura H (2005) Animal model of menopausal depressive-like state in female mice: prolongation of immobility time in the forced swimming test following ovariectomy. Psychopharmacol Berl 183:300–307
Bekku N, Yoshimura H, Araki H (2006) Factors producing a menopausal depressive-like state in mice following ovariectomy. Psychopharmacol Berl 187:170–180
Biegon A, Reches A, Snyder L, McEwen BS (1983) Serotonergic and noradrenergic receptors in the rat brain: modulation by chronic exposure to ovarian hormones. Life Sci 32:2015–2021
Blier P, Ward NM (2003) Is there a role for 5-HT1A agonists in the treatment of depression? Biol Psychiatry 53:193–203
Borsini F, Meli A (1988) Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology 94:147–160
Bourin M, Fiocco AJ, Clenet F (2001) How valuable are animal models in defining antidepressant activity? Hum Psychopharmacol Clin Exp 16:9–21
Bourin M, Masse F, Dailly E, Hascoet M (2005) Anxiolytic-like effect of milnacipran in the four-plate test in mice: mechanism of action. Pharmacol Biochem Behav 81:645–656
Carr MN, Bekku N, Yoshimura H (2006) Identification of anxiolytic ingredients in ginseng root using the elevated plus-maze test in mice. Eur J Pharmacol 531:160–165
Cryan JF, Markou A, Lucki I (2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23:238–245
Cyr M, Bosse R, Di Paolo T (1998) Gonadal hormones modulate 5-hydroxytryptamine2A receptors: emphasis on the rat frontal cortex. Neuroscience 83:829–836
Cyr M, Landry M, Di Paolo T (2000) Modulation by estrogen-receptor directed drugs of 5-hydroxytryptamine-2A receptors in rat brain. Neuropsychopharmacology 23:69–78
Daayana S, Holland CM (2009) Hormone replacement therapy and the endometrium. Menopause Int 15:134–138
Dang H, Chen Y, Liu X, Wang Q, Wang L, Jia W, Wang Y (2009) Antidepressant effects of ginseng total saponins in the forced swimming test and chronic mild stress models of depression. Prog Neuro-psychopharmacol Biol Psychiatry 33:1417–1424
Einat H (2007) Chronic oral administration of ginseng extract results in behavioral change but has no effects in mice models of affective and anxiety disorders. Phytother Res 21:62–66
Eydie L, Moses-Kolko SL, Berga PJ, Greer GS, Meltzer CC, Drevets WC (2003) Widespread increases of cortical serotonin type 2A receptor availability after hormone therapy in euthymic postmenopausal. Fertil Steril 80:554–559
Feld J, Halbreich U, Karkun S (2005) The association of perimenopausal mood disorders with other reproductive-related disorders. CNS Spectr 10:461–470
Geller SE, Studee L (2007) Botanical and dietary supplements for mood and anxiety in menopausal women. Menopause 14:541–549
Goodnick PJ, Chaudry T, Artadi J, Arcey S (2000) Women’s issues in mood disorders. Expert Opin Pharmacother 1:903–916
Hascoet M, Bourin M, Claude-Colombel M, Fiocco AJ, Baker GB (2000) Anxiolytic-like effects of antidepressants after acute administration in a four-plate test in mice. Pharmacol Biochem Behav 65:339–344
Hasegawa H, Sung JH, Matsumiya S, Uchiyama M (1996) Main ginseng saponin metabolites formed by intestinal bacteria. Planta Med 62:453–457
Karikura M, Miyase T, Tanizawa H, Taniyama T, Takino Y (1991) Studies on absorption, distribution, excretion and metabolism of ginseng saponins. VII. Comparison of the decomposition modes of ginsenoside-Rb1 and -Rb2 in the digestive tract of rats. Chem Pharm Bull 39:2357–2361
Kitagawa I, Taniyama T, Shibuya H, Noda T, Yoshikawa M (1987) Chemical studies on crude drug processing. V. On the constituents of ginseng radix rubra (2): comparison of the constituents of white ginseng and red ginseng prepared from the same Panax ginseng root. Yakugaku Zasshi 107:495–505
Kugaya A, Epperson CN, Zoghbi S, van Dyck CH, Hou Y, Fujita M, Staley JK, Garg PK, Seibyl JP, Innis RB (2003) Increase in prefrontal cortex serotonin2A receptors following estrogen treatment in postmenopausal women. Am J Psychiatry 160:1522–1524
Leysen JE, Gommeren W, Janssen PF, Van Gompel P, Janssen PA (1988) Receptor interactions of dopamine and serotonin antagonists: binding in vitro and vivo and receptor regulation. Psychopharmacol Ser 5:12–26
Lucki I (1991) Behavioral studies of serotonin receptor agonists as antidepressant drugs. J Clin Psychiatry 52(Suppl):24–31
Neves-E-Castro M (2008) Association of ovarian and uterine cancers with postmenopausal hormonal treatments. Clin Obstet Gynecol 51:607–617
Odani T, Tanizawa H, Takino Y (1983) Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. III. The absorption, distribution and excretion of ginsenoside Rb1 in the rat. Chem Pharm Bull 31:1059–1066
Petit-Demouliere B, Chenu F, Bourin M (2005) Forced swimming test in mice: a review of antidepressant activity. Psychopharmacol Berl 177:245–255
Ripoll N, Hascoet M, Bourin M (2006) Implication of 5-HT2A subtype receptors in DOI activity in the four-plates test–retest paradigm in mice. Behav Brain Res 166:131–139
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, Writing Group for the Women’s Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women’s health initiative randomized controlled trial. JAMA 17(288):321–333
Rouillon F (1999) Anxiety with depression: a treatment need. Eur Neuropsychopharmacol 9(suppl 3):87–92
Samukawa K, Yamashita H, Matsuda H, Kubo M (1995a) Simultaneous analysis of ginsenosides of various ginseng radix by HPLC. Yakugaku Zasshi 115:241–249
Samukawa K, Yamashita H, Matsuda H, Kubo M (1995b) Simultaneous analysis of saponins in ginseng radix by high performance liquid chromatography. Chem Pharm Bull 43:137–141
Seeman MV, Ross LE (2007) Sex steroids, response to stress and susceptibility to depression. In: Fink George (ed.) Encyclopedia of stress, 2nd ed. Elsevier, Inc, pp 474–479
Sipe K, Leventhal L, Burroughs K, Cosmi S, Johnston GH, Deecher DC (2004) Serotonin 2A receptors modulate tail-skin temperature in two rodent models of estrogen deficiency-related thermoregulatory dysfunction. Brain Res 1028:191–202
Sloan DM, Kornstein SG (2003) Gender differences in depression and response to antidepressant treatment. Psychiatr Clin North Am 26:581–594
Soldati F, Tanaka O (1984) Panax ginseng: relation between age of plant and content of ginsenosides. Planta Med 50:351–352
Studd J, Panay N (2009) Are oestrogens useful for the treatment of depression in women? Best Pract Res Clin Obstet Gynaecol 23:63–71
Tanaka O, Kasai R (1984) Saponins of ginseng and related plants. In: Herz W, Grisebach H, Kirby GW, Tamm Ch (eds) Fortschritte der chemie organischer naturstoffe/Progress in the chemistry of organic natural products, vol 46. Springer, New York, pp 1–65
Tanaka O, Han EC, Yamaguchi H, Matsuura H, Murakami T, Taniyama T, Yoshikawa M (2000) Saponins of plants of Panax species collected in Central Nepal, and their chemotaxonomical significance. III Chem Pharm Bull 48:889–892
Tode T, Kikuchi Y, Hirata J, Kita T, Nakata H, Nagata I (1999) Effect of Korean red ginseng on psychological functions in patients with severe climacteric syndromes. Int J Gynecol Obstet 67:169–174
Wetzler S, Katz MM (1989) Problems with the differentiation of anxiety and depression. J Psychiatr Res 23:1–12
Wiklund IK, Mattsson LA, Lindgren R, Limoni C (1999) Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, placebo-controlled trial. Swedish Alternative Medicine Group. Int J Clin Pharmacol Res 19:89–99
Yoshimura H (1987) Studies contrasting drug effects on reproduction induced agonistic behaviour in male and female mice. In: Olivier B, Mos J, Brain PF (eds) Ethopharmacology of agonistic behaviour in animals and humans. Martinus Nijhoff, Dordrecht, pp 94–109
Yoshimura H, Ogawa N (1989) Acute and chronic effects of psychotropic drugs on maternal aggression in mice. Psychopharmacol Berl 97:339–342
Yoshimura H, Ogawa N (1991) Ethopharmacology of maternal aggression in mice: effects of diazepam and SM-3997. Eur J Pharmacol 200:147–153
Yoshimura H, Watanabe K, Ogawa N (1988a) Psychotropic effects of ginseng saponins on agonistic behavior between resident and intruder mice. Eur J Pharmacol 146:291–297
Yoshimura H, Watanabe K, Ogawa N (1988b) Acute and chronic effects of ginseng saponins on maternal aggression in mice. Eur J Pharmacol 150:319–324
Acknowledgments
This research was supported, in part, by a research grant from the Medical Society for Ginseng Research. We are indebted to Drs. Masazumi Miyakoshi and Toshiyuki Murakami, Natural Products Research Department, Maruzen Pharmaceuticals (Hiroshima, Japan), for donating the ginsenoside Rb1 metabolites following the determination of purity. Dr. Keiichi Samukawa, an academic advisor to Ohki Pharmaceuticals (Tokyo, Japan), generously supplied ginsenosides of high purity.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yamada, N., Araki, H. & Yoshimura, H. Identification of antidepressant-like ingredients in ginseng root (Panax ginseng C.A. Meyer) using a menopausal depressive-like state in female mice: participation of 5-HT2A receptors. Psychopharmacology 216, 589–599 (2011). https://doi.org/10.1007/s00213-011-2252-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-011-2252-1